Reactivity of T cells with grass pollen allergen extract and allergoid

被引:30
作者
Kahlert, H [1 ]
Stüwe, HT [1 ]
Cromwell, O [1 ]
Fiebig, H [1 ]
机构
[1] Joachim Ganzer KG, Allergopharma, D-21465 Reinbek, Germany
关键词
grass allergen; grass allergoid; T cell; peripheral blood mononuclear cells; interleukin-5; interferon-gamma; antigen presentation; dendritic cell; T cell clones; Phl p 5;
D O I
10.1159/000024233
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Successful allergen-specific immunotherapy is achieved with progressively increasing doses of allergen or allergoid. In order to gain further insight into the mechanism of action of allergoids several in vitro investigations were conducted. Methods: Peripheral blood mononuclear cells (PBMC) from grass pollen allergic and nonallergic subjects were stimulated with either grass pollen extract or allergoid and the proliferation and cytokine production (IL-5, IFN-gamma) were measured. Similar investigations were performed with Phl p 5-specific T cell lines (TCL) and clones (TCC). Dendritic cells and PBMC were compared in terms of their relative efficacies as antigen-presenting cells. Results: Both allergen and allergoid induced proliferation and Th2 and Th1 cytokine synthesis by PBMC of allergic subjects, whereas PBMC of nonallergic subjects did not produce IL-5. The maximum level of IL-5 was obtained with a lower concentration than was necessary for maximal IFN-gamma production. Higher stimulation doses of allergen and allergoid shifted the cytokine profiles towards a Th1 phenotype. TCL and TCC clearly showed reactivity with both allergen and allergoid when using autologous PBMC for antigen presentation, but compared with the native allergen the reactivity of the allergoid was reduced with most of the TCC. Using dendritic cells for antigen presentation a pronounced increase of stimulation of the TCC especially for the allergoids becomes obvious. Conclusion: In common with grass pollen allergen the corresponding allergoids possess a strong allergen-specific T cell-stimulating capacity. However, the degree of T cell stimulation by the allergoid seems to be dependent on the type of the antigen-presenting cell. Both, allergen and allergoid, can modulate T cell responses in a dose-dependent manner.
引用
收藏
页码:146 / 157
页数:12
相关论文
共 66 条
[51]  
Schramm G, 1999, J IMMUNOL, V162, P2406
[52]   Dendritic cells: From ignored cells to major players in T-cell-mediated immunity [J].
Schuler, G ;
Thurner, B ;
Romani, N .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1997, 112 (04) :317-322
[53]   ALLERGEN IMMUNOTHERAPY DECREASES INTERLEUKIN-4 PRODUCTION IN CD4+ T-CELLS FROM ALLERGIC INDIVIDUALS [J].
SECRIST, H ;
CHELEN, CJ ;
WEN, Y ;
MARSHALL, JD ;
UMETSU, DT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2123-2130
[54]   INTERLEUKIN-4 PRODUCTION BY CD4(+) T-CELLS FROM ALLERGIC INDIVIDUALS IS MODULATED BY ANTIGEN CONCENTRATION AND ANTIGEN-PRESENTING CELL-TYPE [J].
SECRIST, H ;
DEKRUYFF, RH ;
UMETSU, DT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :1081-1089
[55]   INDUCTION OF T-CELL ANERGY BY ALTERED T-CELL-RECEPTOR LIGAND ON LIVE ANTIGEN-PRESENTING CELLS [J].
SLOANLANCASTER, J ;
EVAVOLD, BD ;
ALLEN, PM .
NATURE, 1993, 363 (6425) :156-159
[56]   Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: Contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2 [J].
Smith, AM ;
Chapman, MD .
MOLECULAR IMMUNOLOGY, 1996, 33 (4-5) :399-405
[57]  
STULL ARTHUR, 1933, JOUR ALLERGY, V4, P455, DOI 10.1016/S0021-8707(33)90098-2
[58]  
TAKATSU K, 1975, J IMMUNOL, V66, P336
[59]   GRASS CONJUVAC .1. IMMUNOGENICITY IN RABBITS, GUINEA-PIGS AND RATS [J].
TAYLOR, WA ;
FRANCIS, DH .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1983, 72 (01) :79-83
[60]   IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: Relationship to expression of allergic disease [J].
Till, S ;
Dickason, R ;
Huston, D ;
Humbert, M ;
Robinson, D ;
Larche, M ;
Durham, S ;
Kay, AB ;
Corrigan, C .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (04) :563-569